A Phase 1/2 Trial of ADI-212 in mCRPC

计划入组 12 人 · 首次发布于 2026 年 8 月 28 日

A Study of SGT-212 Gene Therapy in Friedreich's Ataxia

计划入组 10 人 · 首次发布于 2025 年 9 月 18 日

Clinical Study to Evaluate the Efficacy and Safety of GNS-212-E in Bowel Preparation for Colonoscopy

计划入组 318 人 · 首次发布于 2024 年 3 月 19 日

ADi

ADI-008

ADI-003

Medigene AG

Germany

MICHIGAN STATE UNIVERSITY

United States

Merck & Co

United States

Adicet Bio Advances Gamma Delta T Cell Therapy Pipeline with FDA Alignment and 2026 Milestones

SEL-212 Demonstrates Improved Outcomes in Refractory Gout Patients

Adimune Advances ADI-100 Towards Clinical Trials for Multiple Autoimmune Diseases